Summary
Sera from 16 patients with mycosis fungoides at various stages of the disease were investigated for the presence of a leukocyte-migration inhibitory factor. The agarose gel technique with human peripheral blood leukocytes as migrating indicator cells was used for the purpose. The migration inhibitory effect of patients sera, pooled AB-sera and sera from control persons was tested on peripheral blood leukocytes from patients and controls. Also upconcentrated sera were used.
The presence of substances with migration inhibitory effect in serum from patients with mycosis fungoides could not be demonstrated. The significance of these findings is discussed.
Zusammenfassung
Das Serum von 16 Patienten mit Mykosis fungoides in verschiedenen Entwicklungsstadien wurde auf das Vorliegen des Leukocytenmigrations-Inhibitor-Faktors untersucht. Die Agarose-Gel-Technik mit menschlichen Leukocyten aus dem Blut als Indikatorzelle wurde methodisch verwandt. Der Leukocyten-migrationshemmende Effekt von AB-Sera und Sera von Kontrollpersonen wurd an peripheren Blutleukocyten der Patienten und Kontrollen getestet. Höher konzentrierte Sera wurden ebenfalls verwandt.
Im Serum von Patienten mit Mykosis fungoides konnten keine Substanzen aufgefunden werden, die einen Leukocyten-migrationshemmenden Effekt besaßen.
Similar content being viewed by others
References
Bendtzen, K., Andersen, V., Bendixen, G.: An in vitro assay of leukocyte migration inhibitory activity from human lymphocytes stimulated with concanavalin A. Acta allerg.30, 133–149 (1975)
Clausen, J. E.: Migration inhibitory effect of cell-free supernatant from tuberculin-stimulated cultures of human mononuclear leukocytes demonstrated by two-step MIF agarose assay. J. Immun.110, 546–551 (1973)
Cohen, S.: Serum migration-inhibitory activity in patients with lymphoproliferative diseases. New Engl. J. Med.290, 882–886 (1974)
Edelson, R. L.: Morphologic and functional properties of the atypical T-lymphocytes of the Sezary syndrome. Mayo Clinic Proc.49, 559–566 (1974)
Flandrian, G., Brouet, J. C.: The Sezary cell. Cytologic, cytochemical and immunologic studies. Mayo Clinic Proc.49, 575–583 (1974)
Lutzner, M.: Cutaneous T-cell lymphomas. The Sezary syndrome, mycosis fungoides, and related disorders. Ann. int. Med.83, 534–552 (1975)
Rocklin, R. E.: Products of activated lymphocytes. Leukocyte inhibitory factor (LIF) distinct from migration inhibitory factor (MIF). J. Immun.112, 1461–1466 (1974)
Salvin, S. B., Younger, J. S., Lederer, L. H.: Migration inhibitory factor and interferon in the circulation of mice with delayed hypersensitivity. Infect. Immun.7, 68–75 (1973)
Stastny, P., Cooke, T. D., Ziff, M.: Production of a macrophage migration inhibitory factor in rabbits with experimental arthritis. Clin. exp. Immun.14, 141–147 (1973)
Szigeti, R., Révész, R., Gerö-Ferencz, E.: The inhibitory effect of leukaemia associated antigen and leukaemia serum on the leukocyte migration of children with acute leukaemia in remission. Acta allerg.29, 288–296 (1974)
Scott, E. J., van, Kalmanson, J. D.: Complete remissions of mycosis fungoides lymphoma induced by topical nitrogen mustard (HN2). Cancer32, 18–30 (1973)
Yamamoto, K., Takahashi, Y.: Macrophage migration inhibition by serum from desensitized animals previously sensitized with tubercle bacilli. Nature (Lond.)233, 261–263 (1971)
Yoshida, T., Cohen, S.: In vivo manifestations of lymphokine and lymphokine activity. Mechanism of cell-mediated immunity, p. 43. Ed. McCluskey, R. T., Cohen, S. New York: J. Wiley and Sons 1974
Yoshida, T.: Migration inhibitory activity in serum and cell supernatants in patients with Sezary syndrome. J. Immun.114, 915–918 (1975)
Zucker-Franklin, D.: Properties of Sezary lymphoid cell. Mayo Clinic Proc.49, 567–574 (1974)
Author information
Authors and Affiliations
Additional information
This work was supported by a grant from the P. Carl Petersens Foundation
Rights and permissions
About this article
Cite this article
Thulin, H. Absence of leukocyte-migration inhibitory factor in serum from patients with mycosis fungoides. Arch. Derm. Res. 257, 157–161 (1976). https://doi.org/10.1007/BF00558089
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00558089